Genetic overlap between schizophrenia and bipolar disorder: A study with AKT1 gene variants and clinical phenotypes

Schizophrenia Research

Volumn 135, Issue 1-3, 2012, Pages 8-14

  Karege, Félicien ^a   Méary, Alexandre ^b,c   Perroud, Nader ^d   Jamain, Stéphane ^b,c   Leboyer, Marion ^b,c   Ballmann, Eladia ^a   Fernandez, Raphael ^a   Malafosse, Alain ^a,d   Schürhoff, Franck ^b,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSERM U955   (France)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

AKT1 gene; Bipolar disorder; Genetic overlap; Mood disorder; Psychosis; Schizophrenia

Indexed keywords

ADULT; AKT1 GENE; ARTICLE; ASIAN; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; EUROPE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 84857232356     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.12.015     Document Type: Article

References (43)

1. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15:6541-6551.
2. Aubry J.M., Schwald M., Ballmann E., Karege F. Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation. Psychopharmacology 2009, 205:419-429.
3. Bajestan S.N., Sabouri A.H., Nakamura M., Takashima H., Keikhaee M.R., Behdani F., Fayyazi M.R., Sargolzaee M.R., Bajestan M.N., Sabouri Z., Khayami E., Haghighi S., Hashemi S.B., Eiraku N., Tufani H., Najmabadi H., Arimura K., Sano A., Osame M. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am. J. Med. Genet B Neuropsychiatr. Genet. 2006, 141B:383-386.
4. Beaulieu J.M., Gainetdinov R.R., Caron M.G. Akt/GSK3 signaling in the action of psychotropic drugs. Annu. Rev. Pharmacol. Toxicol. 2009, 49:327-347.
5. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 57:289-300.
6. Brazil D.P., Yang Z.Z., Hemmings B.A. Advances in protein kinase B: AKTion on multiple fronts. Trends Biochem. Sci. 2004, 29:233-242.
7. Cardno A.G., Rijsdijk F.V., Sham P.C., Murray R.M., McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am. J. Psychiatry 2002, 159:539-545.
8. Carroll L.S., Owen M.J. Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med. 2009, 1:1-102.
9. Ciapperelli A., Dell'Osso L., Bandettini di Poggio A., Carmassi C., Cecconi D., Cassano G.B. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder or psychotic bipolar disorder: A naturalistic 48-month follow-up study. J. Clin. Psychiatry 2003, 64:451-458.
10. Craddock N., O'Donovan M.C., Owen M.J. The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 2005, 42:193-204.
11. Craddock N., O'Donovan M.C., Owen M.J. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. Schizophr. Bull. 2009, 35:482-490.
12. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004, 36:131-137.
13. Green E.K., Raybould R., Macgregor S., Gordon-Smith K., Heron J., Hyde S., Grozeva D., Hamshere M., Williams N., Owen M.J., O'Donovan M.C., Jones L., Jones I., Kirov G., Craddock N. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch. Gen. Psychiatry 2005, 62:642-652.
14. Grimes C.A., Jope R.S. The multifcetsd rôles of glycogen synthase kinase 3ß in cellular signaling. Prog. Neurobiol. 2001, 65:1025-1035.
15. Grozeva D., Kirov G., Ivanov D., Jones I.R. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 2010, 67:318-327.
16. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Inada T., Ozaki N. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol. Psychiatry 2004, 56:698-700.
17. Joo E.-J., Lee K.-Y., Jeong S.-H., Roh M.-S., Kim S.H., Ahn Y.-M., Kim Y.S. AKT1 Grene Polymorphisms and Obstetric Complications in the Patients and Schizophrenia. Psychiatry Invest. 2009, 6:102-107.
18. Kalkman H.O. The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol. Ther. 2006, 110:117-134.
19. Kang U.G., Seo M.S., Roh M.S., Kim Y., Yoon S.C., Kim Y.S. The effects of clozapine on the GSK-3-mediated signaling pathway. FEBS Lett. 2004, 560:11-119.
20. Karege F., Perroud N., Burkhardt S., Schwald M., Ballmann E., La Harpe R., Malafosse A. Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol. Psychiatry 2007, 61:240-245.
21. Karege F., Perroud N., Schüroff F., Méary A., Marillier G., Burkhardt S., Ballmann E., Fernandez R., Leboyer M., La Harpe R., Malafosse A. Association of AKT1 gene variants and protein expression in both schizophrenia and Bipolar disorder. Gene Brain Behav. 2010, 9:503-511.
22. Kraepelin E. Manic-depressive insanity and paranoa 1919, Livingstone, Edinburgh.
23. Lee K.Y., Joo E.J., Jeong S.H., Kang U.G., Roh M.S., Kim S.H., Song J.Y., Hwang J.Y., Kim S.G., Lee N., Ahn Y.M., Kim Y.S. No association between AKT1 polymorphism and schizophrenia: a case-control study in a Korean population and a meta-analysis. Neurosci. Res. 2010, 66:238-245.
24. Lawlor, M.A., Alessi, D.R., 2001. PKB/Akt: a key mediator of cell proliferation, survival and.
25. Maier W., Zobel A., Wagner M. Schizophrenia and bipolar disorder: differences and overlaps. Curr. Opin. Psychiatry 2006, 19:165-170.
26. Maloney A.E., Sikich L. Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. Neuropsychiatr. Dis. Treat. 2010, 6:749-766.
27. Marneros A., Akiskal H.S. The overlap of affective and schizophrenic spectra 2007, Cambridge University Press, Cambridge, UK.
28. Mathur A., Law M.H., Megson I.L., Shaw D.J., Wei J. Genetic Association of the AKT1 gene with schizophrenia in a British population. Psychiatr. Genet. 2010, 20:118-122.
29. Moskvina V., Craddock N., Holmas P., Nikolov I. Gene-wide analyses of genome-wide associationdata sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and overlap in genetic risk. Mol. Psychiatry 2009, 14:252-260.
30. Norton N., Williams H.J., Dwyer S., Carroll L., Peirce T., Moskvina V., Segurado R., Nikolov I., Williams N.M., Ikeda M., Iwata N., Owen M.J., O'Donovan M.C. Association analysis of AKT1 and schizophrenia in a UK case control sample. Schizophr. Res. 2007, 93:58-65.
31. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 1994, 51:849-859.
32. Ohtsuki T., Inada T., Arinami T. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol. Psychiatry 2004, 9:981-983.
33. Pandey G.N., Ren X., Rizavi H.S., Dwivedi Y. Glyocogen synthase kinase-3-beta in the platelets of patients with mood disorders: effect of treatment. J. Psychiatr. Res. 2010, 44:143-148.
34. Preisig M., Fenton B.T., Matthey M.L. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249:174-179.
35. Sanchez M.G., Ruiz-Liorente L., Sanchez A.M., Diaz-Liviada I. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoïd receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cell. Signal. 2003, 15:851-859.
36. Schurhoff F., Bellivier F., Jouvent R., Mouren-Simeoni M.C., Bouvard M., Allilaire J.F., Leboyer M. Early and late onset bipolar disorders: two different forms of manic-depressive illness?. J. Affect. Disord. 2000, 58:215-221.
37. Schwab S.G., Hoefgen B., Hanses C., Hassenbach M.B., Albus M., Lerer B., Trixler M., Maier W., Wildenauer D.B. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol. Psychiatry 2005, 58:446-450.
38. Shao L., Vawter M.P. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol. Psychiatry 2008, 64:89-97.
39. Thiselton D.L., Vladimirov V.I., Kuo P.H., McClay J., Wormley B., Fanous A., O'Neill F.A., Walsh D., Van den Oord E.J., Kendler K.S., Riley B.P. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol. Psychiatry 2008, 63:449-457.
40. Toyota T., Yamada K., Detera-Wadleigh S.D., Yoshikawa T. Analysis of a cluster of polymorphisms in AKT1 gene in bipolar pedigrees: a family-based association study. Neurosci. Lett. 2003, 339:5-8.
41. Van Winkel R., Genetic Risk and Outcome of Psychosis (GROUP) investigators Family-based analysis of genetic variation underlying psychosis-inducing effects of Cannabis. Sibling analysis and proband follow-up. Arch. Gen. Psychiatry 2011, 68:148-157.
42. Walss-Bass C., Escamilla M.A., Raventos H. Evidence of genetic overlap of schizophrenia and bipolar disorder: linkage disequilibrium analysis of chromosome 18 in the Costa Rican population. Am. J. Med. Genet. 2005, 139B:54-60.
43. Xu M.Q., Xing Q.H., Zheng Y.L., Li S., Gao J.J., He G., Guo T.W., Feng G.Y., Xu F., He L. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J. Clin. Psychiatry 2007, 68:1358-1367.